Oct 03rd 2013 - Edison Investment Research today published a report on Animalcare (ANCR.L, LSE:ANCR, LON:ANCR) entitled "Laying Down Solid Foundations". In summary, the report says:
FY13 results came in ahead of expectations, driven by a strong rebound in Licensed Veterinary Medicines. It is this business that underpins the medium-term outlook, with new product development the key to countering rising competitive pressures. The transition towards higher-value enhanced generics means costlier and more protracted development, but should generate higher and more resilient earnings.
Edison Investment Research is a leading international investment research company. It has won industry recognition, with awards both in the UK and internationally. The team of 95 includes over 60 analysts supported by a department of supervisory analysts, editors and assistants. Edison writes on more than 400 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison’s research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. Edison, founded in 2003, has offices in London, New York and Sydney and is authorised and regulated by the Financial Services Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). more »